» Articles » PMID: 23790626

TALENs: Customizable Molecular DNA Scissors for Genome Engineering of Plants

Overview
Publisher Science Press
Specialty Genetics
Date 2013 Jun 25
PMID 23790626
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Precise genome modification with engineered nucleases is a powerful tool for studying basic biology and applied biotechnology. Transcription activator-like effector nucleases (TALENs), consisting of an engineered specific (TALE) DNA binding domain and a Fok I cleavage domain, are newly developed versatile reagents for genome engineering in different organisms. Because of the simplicity of the DNA recognition code and their modular assembly, TALENs can act as customizable molecular DNA scissors inducing double-strand breaks (DSBs) at given genomic location. Thus, they provide a valuable approach to targeted genome modifications such as mutations, insertions, replacements or chromosome rearrangements. In this article, we review the development of TALENs, and summarize the principles and tools for TALEN-mediated gene targeting in plant cells, as well as current and potential strategies for use in plant research and crop improvement.

Citing Articles

CRISPR/Cas technology: fueling the future of Biofuel production with sugarcane.

Ghane A, Malhotra P, Sanghera G, Verma S, Jamwal N, Kashyap L Funct Integr Genomics. 2024; 24(6):205.

PMID: 39495322 DOI: 10.1007/s10142-024-01487-9.


Cardiomyopathy: pathogenesis and therapeutic interventions.

Huang S, Li J, Li Q, Wang Q, Zhou X, Chen J MedComm (2020). 2024; 5(11):e772.

PMID: 39465141 PMC: 11502724. DOI: 10.1002/mco2.772.


Identification, charectrization and genetic transformation of lignin and pectin polysaccharides through CRISPR/Cas9 in Nicotiana tobacum.

Ahmed R, Ren A, Alshaya D, Fiaz S, Kong Y, Liaqat S Funct Integr Genomics. 2024; 24(5):188.

PMID: 39400746 DOI: 10.1007/s10142-024-01472-2.


Precise genome-editing in human diseases: mechanisms, strategies and applications.

Zheng Y, Li Y, Zhou K, Li T, VanDusen N, Hua Y Signal Transduct Target Ther. 2024; 9(1):47.

PMID: 38409199 PMC: 10897424. DOI: 10.1038/s41392-024-01750-2.


Genome Editing and Diabetic Cardiomyopathy.

Kambis T, Mishra P Adv Exp Med Biol. 2022; 1396:103-114.

PMID: 36454462 PMC: 10155862. DOI: 10.1007/978-981-19-5642-3_7.